Purilogics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 8


  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $48.9M

Purilogics General Information


Developer of disposable membrane chromatography columns designed to purify biologics for research and early-stage drug trials. The company's columns are used for the downstream purification of a range of therapeutic agents that include monoclonal antibodies, recombinant and fusion proteins, enabling researchers to improve the speed of early-stage development to get biologics to market faster where they are needed, to serve the large and growing population of patients with long-term, chronic conditions such as cancers, cardiovascular diseases and autoimmune disorders.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • ITOR 900B West Faris Road
  • Greenville, SC 29605
  • United States
+1 (864) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Purilogics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 13-Jun-2022 $48.9M 000.00 Completed Generating Revenue
7. Grant 01-Aug-2021 00000 Completed Generating Revenue
6. Grant 01-Aug-2021 00000 Completed Generating Revenue
5. Grant 30-Aug-2018 00000 Completed Generating Revenue
4. Grant 01-Jan-2017 00.000 Completed Generating Revenue
3. Grant 01-Jan-2016 00000 Completed Generating Revenue
2. Accelerator/Incubator 16-Apr-2015 Completed Startup
1. Grant $80K Completed Startup
To view Purilogics’s complete valuation and funding history, request access »

Purilogics Comparisons

HQ Location
Total Raised
Post Valuation
Developer of disposable membrane chromatography columns designed to purify biologics for research and early-stage drug t
Drug Discovery
Greenville, SC
8 As of 2022
00.00 0000-00-00


quat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolo
East Rutherford, NJ
0000 As of 0000
000000000 00000


it, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim a
00000 00000000000000
Torrance, CA
000 As of 0000
0000 0000-00-00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Purilogics Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cambrex Private Equity-Backed East Rutherford, NJ 0000 00000 000000000 00000
0000000000 Corporate Backed or Acquired Torrance, CA 000 000000&0
You’re viewing 2 of 2 competitors. Get the full list »

Purilogics Patents

Purilogics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230010637-A1 Epoxide-activated substrates and hydrophobic interaction chromatography made therefrom for polynucleotide purification Pending 12-Jul-2021 00000000

Purilogics Executive Team (2)

Name Title Board Seat Contact Info
Jinxiang Zhou Ph.D Co-Founder & Director
Scott Husson Ph.D Co-Founder
To view Purilogics’s complete executive team members history, request access »

Purilogics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Purilogics Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Clemson University Foundation Limited Partner 000 0000 000000 0
Groupe Michelin Corporation 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
SC EPSCoR/IDeA Foundation Government 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »